Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.
Department of Biological Sciences, University of Texas at Dallas, Richardson, Texas, USA.
J Clin Microbiol. 2021 Aug 18;59(9):e0058521. doi: 10.1128/JCM.00585-21.
Metronidazole resistance in clinical Clostridioides difficile is often described as unstable, since resistant strains reportedly appear susceptible following freezer storage or brief passage. This has presented a conundrum for adopting susceptibility testing to accurately evaluate the connection between metronidazole resistance and decreased clinical efficacy of metronidazole in patients with C. difficile infections (CDIs). We discovered that supplementation of microbiological media with the metalloporphyrin heme is crucial for detection of metronidazole-resistant C. difficile using the agar dilution susceptibility testing method. Known metronidazole-resistant strains appeared susceptible to metronidazole in media lacking heme. Similarly, these resistant strains exhibited increased susceptibility to metronidazole when tested on heme-containing agars that were exposed to room light for more than 1 day, likely due to heme photodecomposition. In parallel experiments, resistance was reproducibly detected when heme-containing agars were either prepared and used on the same day or protected from light and then used on subsequent days. Notably, heme did not influence the susceptibilities of drug-susceptible strains that were of the same ribotype as the resistant strains. These findings firmly show that the consistent detection of metronidazole-resistant C. difficile is dependent upon heme and its protection from light. Studies are warranted to determine the extent to which this heme-associated metronidazole-resistant phenotype affects the clinical efficacy of metronidazole in CDI and the underlying genetic and biochemical mechanisms.
临床艰难梭菌的甲硝唑耐药性通常被描述为不稳定的,因为据报道,在冷冻储存或短暂传代后,耐药菌株会表现出敏感。这给采用药敏试验来准确评估甲硝唑耐药性与甲硝唑治疗艰难梭菌感染(CDI)患者的临床疗效下降之间的关系带来了难题。我们发现,在微生物培养基中补充金属卟啉血红素对于使用琼脂稀释药敏试验方法检测甲硝唑耐药艰难梭菌至关重要。已知的甲硝唑耐药菌株在缺乏血红素的培养基中对甲硝唑表现出敏感。同样,这些耐药菌株在含有血红素的琼脂上进行测试时,当暴露在光照下超过 1 天时,对甲硝唑的敏感性增加,这可能是由于血红素光分解。在平行实验中,当含有血红素的琼脂在同一天制备和使用,或避光保存并在随后的几天使用时,耐药性可重复检测到。值得注意的是,血红素并不影响与耐药菌株具有相同核糖体型的药物敏感菌株的药敏性。这些发现确凿地表明,甲硝唑耐药艰难梭菌的一致检测取决于血红素及其对光的保护。有必要进行研究,以确定这种血红素相关的甲硝唑耐药表型在多大程度上影响甲硝唑治疗 CDI 的临床疗效,以及潜在的遗传和生化机制。